COVID-19 temporarily reversed South Africa’s hard-won reduction in maternal mortality, but the death rate has now stabilised, and hopes are high that the downward trend will resume. However, if experts are right, we’re missing some crucial interventions that would further prevent what are avoidable deaths. Chris Bateman talks to some of the leading lights in the field.
After a decade at the helm of the country’s primary health research funder, Professor Glenda Gray will focus again on doing the science. She tells Spotlight’s Biénne Huisman about her childhood, her passion for research, administering multi-million dollar grants, and a heated argument in the bathroom with an ANC bigwig.
Some researchers argue that South Africa should look into using “expired” doses of antivenom if the country once again struggles to make enough of the treatment – something which happened in 2023. In part 2 of a Spotlight special series on snake antivenom, Jesse Copelyn outlines the case for extending the shelf-life and goes over some exciting, but very early, research on a new form of antivenom.
With South Africa’s healthcare system facing a myriad challenges, experts at a health conference have put forward a range of practical solutions to address some of the country’s pressing issues. Ufrieda Ho rounds up some of the proposed solutions to improve patient care, including the use of public-private partnerships.
The African Centre for Disease Control and World Health Organization have raised the alarm following a drastic uptick in mpox cases. This surge is being driven by a new strain of the virus. Elri Voigt reports about what we know so far and potential implications for South Africa.
With varying degrees of success, artificial intelligence has begun to play the role of research assistant, radiologist, health educator, and even therapist. In this Spotlight special briefing, Jesse Copelyn tries to see past the hype and pin-points the most immediate implications of these new technologies for healthcare in South Africa.
A Competition Commission probe recently resulted in a patent on an important tuberculosis medicine being dropped in South Africa. Twenty years ago, a similar Competition Commission case resulted in a settlement that helped drive down the prices of several antiretrovirals, thereby helping to set the stage for the country’s HIV treatment programme. Fatima Hassan and Leena Menghaney connect the dots between the two landmark cases and map out what has and has not changed over the last two decades.
The only full-time nurse at the Saartjie Baartman Centre, Sister Leonie Weyers, is not only a caregiver to her patients but also helps them to “feel beautiful” again. Biénne Huisman spent time with her at the shelter situated on gang-war turf in Manenberg.
In recent years, shortages of snake antivenom have plagued South Africa and much of the globe. Even when antivenom is available, potentially serious side effects often limit its use. Jesse Copelyn unpacks the fascinating details behind the antivenom products that might save your life and takes a look at a promising experimental treatment.
Burn injury has been described as the forgotten global public health crisis. Dr Nikki Allorto says that while it may be a neglected issue in South Africa, she is making sure her patients feel seen, heard and cared for. Sue Segar spent time with her on ward and clinic rounds at Greys Hospital in KwaZulu-Natal.
Sister Sandra Bryant runs her clinic in a lilac painted room, where glitter cream and a disco ball does not seem out of place next to scissors, syringes, and needles. She tells Spotlight’s Biénne Huisman about working with Professor Christiaan Barnard, the adrenaline of being in the operating theater, and why she has a tattoo of an anatomical heart.
The South African government has adopted a national target to bring the blood sugar levels of people with diabetes under control. But beyond the target, the country’s response to diabetes is falling far short. In this Spotlight special briefing, Catherine Tomlinson looks at what the country needs to do to better manage this often fatal disease and how we can draw lessons from the response to HIV.
